oxandrolone has been researched along with HIV Wasting Syndrome in 17 studies
Oxandrolone: A synthetic hormone with anabolic and androgenic properties.
HIV Wasting Syndrome: Involuntary weight loss of greater than 10 percent associated with intermittent or constant fever and chronic diarrhea or fatigue for more than 30 days in the absence of a defined cause other than HIV infection. A constant feature is major muscle wasting with scattered myofiber degeneration. A variety of etiologies, which vary among patients, contributes to this syndrome. (From Harrison's Principles of Internal Medicine, 13th ed, p1611).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Oxandrolone, an oral drug that promotes weight gain in people experiencing weight loss, has been approved by the Food and Drug Administration (FDA) for patients with HIV." | 7.69 | Oxandrolone for weight gain. ( , 1997) |
| "Oxandrolone, an oral drug that promotes weight gain in people experiencing weight loss, has been approved by the Food and Drug Administration (FDA) for patients with HIV." | 3.69 | Oxandrolone for weight gain. ( , 1997) |
| "Treatment with oxandrolone for 3 months in HIV-infected children was well-tolerated, safe, and associated with markers of anabolism." | 2.69 | Evaluation of the effects of oxandrolone on malnourished HIV-positive pediatric patients. ( Barton, N; Church, JA; Fox-Wheeler, S; Gilsanz, V; Haight, M; Heller, L; Kaufman, F; Loro, ML; Salata, CM; Umman, GC, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (47.06) | 18.2507 |
| 2000's | 9 (52.94) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dworkin, MS | 1 |
| Williamson, JM | 1 |
| Shevitz, AH | 2 |
| Wilson, IB | 1 |
| McDermott, AY | 1 |
| Spiegelman, D | 1 |
| Skinner, SC | 1 |
| Antonsson, K | 1 |
| Layne, JE | 1 |
| Beaston-Blaakman, A | 2 |
| Shepard, DS | 2 |
| Gorbach, SL | 1 |
| James, JS | 1 |
| Hatoum, HT | 1 |
| Walton, SM | 1 |
| Stone, N | 1 |
| Segal, DM | 1 |
| Perez, M | 1 |
| Shapshak, P | 1 |
| Strawford, A | 1 |
| Barbieri, T | 1 |
| Van Loan, M | 1 |
| Parks, E | 1 |
| Catlin, D | 1 |
| Barton, N | 2 |
| Neese, R | 1 |
| Christiansen, M | 1 |
| King, J | 1 |
| Hellerstein, MK | 1 |
| Fox-Wheeler, S | 1 |
| Heller, L | 1 |
| Salata, CM | 1 |
| Kaufman, F | 1 |
| Loro, ML | 1 |
| Gilsanz, V | 1 |
| Haight, M | 1 |
| Umman, GC | 1 |
| Church, JA | 1 |
| Romeyn, M | 1 |
| Gunn, N | 1 |
| Bell, LE | 1 |
| Corcoran, C | 1 |
| Grinspoon, S | 1 |
| Langer, CJ | 1 |
| Hoffman, JP | 1 |
| Ottery, FD | 1 |
| Yarasheski, KE | 1 |
| Roubenoff, R | 1 |
| Mikulin, L | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Mirtazapine Versus Placebo on Appetite, Nutritional Status and Quality of Life in Non-small Cell Lung cáncer Patients With Anorexia; Randomized Double-blind Clinical Trial.[NCT04748523] | 86 participants (Actual) | Interventional | 2018-08-29 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for oxandrolone and HIV Wasting Syndrome
| Article | Year |
|---|---|
Clinical significance of weight loss in cancer patients: rationale for the use of anabolic agents in the treatment of cancer-related cachexia.
Topics: Anabolic Agents; Appetite Stimulants; Body Weight; Cachexia; HIV Wasting Syndrome; Humans; Neoplasms | 2001 |
Exercise treatment for HIV-associated metabolic and anthropomorphic complications.
Topics: Acquired Immunodeficiency Syndrome; Anabolic Agents; Anthropometry; Antiretroviral Therapy, Highly A | 2001 |
4 trials available for oxandrolone and HIV Wasting Syndrome
| Article | Year |
|---|---|
A comparison of the clinical and cost-effectiveness of 3 intervention strategies for AIDS wasting.
Topics: Adult; Anabolic Agents; Antiretroviral Therapy, Highly Active; Body Composition; Cost-Benefit Analys | 2005 |
Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: a randomized controlled trial.
Topics: Adult; Anabolic Agents; Blood Chemical Analysis; Body Composition; Double-Blind Method; Energy Intak | 1999 |
Evaluation of the effects of oxandrolone on malnourished HIV-positive pediatric patients.
Topics: Adolescent; Anabolic Agents; Body Weight; CD4 Lymphocyte Count; Chi-Square Distribution; Child; Chil | 1999 |
Anabolic steroid now available.
Topics: Anabolic Agents; Body Weight; Double-Blind Method; HIV Wasting Syndrome; Humans; Oxandrolone | 1996 |
11 other studies available for oxandrolone and HIV Wasting Syndrome
| Article | Year |
|---|---|
AIDS wasting syndrome: trends, influence on opportunistic infections, and survival.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Anabolic Agents; Anti-HIV Agents; Centers | 2003 |
Involuntary weight loss: interview with Lisa Capaldini, M.D.
Topics: Appetite Stimulants; Body Composition; HIV Wasting Syndrome; Humans; Megestrol Acetate; Oxandrolone; | 2005 |
Discussion of "Comparison of clinical and cost-effectiveness of 3 intervention strategies for HIV wasting".
Topics: Combined Modality Therapy; Cost-Benefit Analysis; HIV Wasting Syndrome; Humans; Oxandrolone; Quality | 2005 |
Cost-effectiveness of clinical interventions for AIDS wasting.
Topics: Anabolic Agents; Antiretroviral Therapy, Highly Active; Boston; Cost-Benefit Analysis; Female; HIV W | 2007 |
Oxandrolone, used for treatment of wasting disease in HIV-1-infected patients, does not diminish the antiviral activity of deoxynucleoside analogues in lymphocyte and macrophage cell cultures.
Topics: Anabolic Agents; Anti-HIV Agents; Cells, Cultured; Dideoxynucleosides; Drug Interactions; HIV Wastin | 1999 |
Resistance exercise and oxandrolone for men with HIV-related weight loss.
Topics: Anabolic Agents; Exercise; Female; HIV Infections; HIV Wasting Syndrome; Humans; Male; Oxandrolone; | 2000 |
Oxandrolone for weight gain.
Topics: Female; HIV Wasting Syndrome; Humans; Male; Oxandrolone; Weight Gain | 1997 |
Women, food and HIV.
Topics: Anabolic Agents; Diet; Female; HIV Infections; HIV Wasting Syndrome; Humans; Nutritional Requirement | 1998 |
The use of testosterone in the AIDS wasting syndrome.
Topics: Anabolic Agents; Body Composition; Female; HIV Wasting Syndrome; Humans; Hypogonadism; Male; Nandrol | 1999 |
Geneva talks metabolism.
Topics: Anabolic Agents; Antiviral Agents; Energy Metabolism; Exercise; HIV Wasting Syndrome; Humans; Lipody | 1998 |
Nutrition and its role in wound healing.
Topics: Adult; Anabolic Agents; Enteral Nutrition; Female; HIV Wasting Syndrome; Humans; Myelitis; Nutrition | 2001 |